Comparison Chart Denali Therapeutics Inc. Sao Paulo
Stocks
D2NL34
BRD2NLBDR008
Biotechnology & Medical Research
|
Market Closed -
Sao Paulo
14:04:39 2026-07-13 EDT
|
5-day change | 1st Jan Change | ||
| 27.06 BRL | -1.31% |
|
-.--% | +25.57% |
| 08-25 | B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating | MT |
| 08-24 | FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DENALI THERAPEUTICS INC. | Bio Therapeutic Drugs | -1.31% | -.--% | +25.57% | +63.41% | - | 3.8B |
-
|
-
|
-
|
- Stock Market
- Stocks
- DNLI Stock
- D2NL34 Stock
- Charts Denali Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
